Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.
Enhanced remyelination following lysolecithin-induced demyelination in mice under treatment with fingolimod (FTY720).
Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.
Refractory acute disseminated encephalomyelitis with anti-galactocerebroside antibody.
Myelitis: Differences between multiple sclerosis and other aetiologies.
Neurodegenerative diseases and therapeutic strategies using iron chelators.
The Neurite Outgrowth Inhibitory Nogo-A-Δ20 Region Is an Intrinsically Disordered Segment Harbouring Three Stretches with Helical Propensity.
Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis.
[Registries for neurological drugs landscape].
Effects of Gadolinium Contrast Agent Administration on Automatic Brain Tissue Classification of Patients with Multiple Sclerosis.
Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes.
Sudden onset of sleep due to hypothalamic lesions in neuromyelitis optica spectrum disorder positive for anti-aquaporin-4 antibody.
A Novel Bmal1 Mutant Mouse Reveals Essential Roles of the C-Terminal Domain on Circadian Rhythms.
GABA transport and neuroinflammation are coupled in multiple sclerosis: Regulation of the GABA transporter-2 by ganaxolone.
[Optic neuropathy after retrobulbar neuritis in multiple sclerosis : Are optical coherence tomography and magnetic resonance imaging useful and necessary follow-up parameters?].
Early treatment with high-dose interferon beta-1areverses cognitive and cortical plasticity deﬁcits in multiple sclerosis.
How do immune cells support and shape the brain in health, disease, and aging?
Biointegrator announced that it has successfully launched Neskler® - a first generic of Gilenya® in Russia and EuroAsian Economic Union
Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica.
Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis.
Laparoscopic implantation of neuromodulators for treating urinary dysfunctions and improving locomotion in multiple sclerosis patients.
Radiolabeling and in vitro / in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment.

Pages